Stocks
Axsome Therapeutics (AXSM) ROE US GAAP (year values) |
||||||||
| 2020 | 2021 | 2022 | 2022 | 2023 | LTM ? | |||
| ROE, % | ? | 37.8% | 33.0% | -170.8% | -180.5% | -125.3% | -334.7% | |
| Changes by years, y/y, % | -2pp | -5pp | -204pp | -10pp | +55pp | |||
Axsome Therapeutics. ROE, %
Axsome Therapeutics. ROE, changes, pp
Axsome Therapeutics (AXSM) ROE US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| ROE, % | ? | -76.9% | -125.3% | -205.8% | -300.0% | -334.7% | -334.7% | |
| Changes by years, y/y, % | +29pp | +55pp | -55pp | -231pp | -258pp | |||
| Changes by quarters, q/q, % | -8pp | -48pp | -80pp | -94pp | -35pp | |||
